false
ar,be,bn,zh-CN,zh-TW,en,fr,de,hi,it,ja,ko,pt,ru,es,sw,vi
Catalog
Didactics
Radiotherapy in Endometrial Cancer and Critiques o ...
Radiotherapy in Endometrial Cancer and Critiques of FIGO 2023
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The speaker discussed the effectiveness of radiotherapy in treating endometrial cancer, highlighting various trials and evidence to support its use. They emphasized the importance of molecular profiling in determining the success of radiotherapy, pointing out different subgroups that may benefit from this treatment approach. Additionally, they touched on the new staging system adopted by FIGO in 2023, integrating molecular classifications and its impact on patient outcomes. The speaker addressed critiques of the new system, including complexity, validation, and cost-effectiveness, providing supporting evidence for its implementation. They concluded that the updated staging system offers improved discrimination and tailored therapy for endometrial cancer patients, ultimately benefiting patient care.
Asset Subtitle
David Gaffney
May 2024
Keywords
radiotherapy
endometrial cancer
molecular profiling
FIGO staging system
patient outcomes
tailored therapy
Contact
education@igcs.org
for assistance.
×